BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Wiskott-Aldrich Syndrome

Below is an extended Wiskott-Aldrich Syndrome patents listing. Click here to return to the Wiskott-Aldrich Syndrome main in depth entry.

Patents :

US Patent No.Title
7247442 Antibodies to HHPEN62 polypeptide
7323311 Methods of obtaining a specific binding member that binds eotaxin
7326690 Modulation of cell fates and activities by phthalazinediones
7329490 Methods for diagnosing schizophrenia by detecting a polymorphism in the KalphaM1 gene
7329504 Methods of preventing or treating cell migration mediated conditions or diseases
7332163 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
7332334 Hematopoietic stem cells treated by in vitro fucosylation and methods of use
7332474 Peptides and related compounds having thrombopoietic activity
7335676 Methods for treating inflammatory conditions or inhibiting JNK
7339049 Polymorphisms in human mitochondrial DNA
7351427 Pharmaceutical composition, a method of preparing it and a method of treatment by use thereof
7320880 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and DNA coding for the same
7319141 Stem cell growth factor-like polypeptides
7319139 TAG-72 specific C.sub.H2 domain deleted antibodies
7250261 EspFu nucleic acids and proteins and uses thereof
7256171 Use of core 2 G1cNAc transferase inhibitors in treating inflammation
7264926 Nucleoside Phosphatase
7267966 Complexity management and analysis of genomic DNA
7271243 Full-length human cDNAs encoding potentially secreted proteins
7288385 Increasing life span by modulation of Smek
7291461 Methods for identifying small molecules that modulate premature translation termination and nonsense mRNA decay
7297329 Mammalian common lymphoid progenitor cell
7312051 Polynucleotides encoding dendritic enriched secreted lymphocyte activation molecule
7314621 Cytidine deaminase
7351566 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552, and 65577 molecules and uses therefor
7351729 JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers
7387900 Colloidal metal compositions and methods
7390637 Keratinocyte derived interferon
7393848 Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds
7393918 Protein binding miniature proteins and uses thereof
7393934 Human G-protein chemokine receptor (CCR5) HDGNR10
7399584 Method of comparing a target nucleic acid and a reference nucleic acid
7399633 Methods for immortalizing cells
7399833 MGDF analogs
7402725 WIP, a WASP-associated protein
7411051 Antibodies to HDPPA04 polypeptide
7381800 Antibodies to HBIMF63 polypeptide
7381554 UDP-N-acetylglucosamine: galactose-.beta.1,3-N-acetylgalactosamine-.alpha.-R/N-acetylglucosamine-.- beta.1,3-N-acetylgalactosamine-.alpha.-R (GlcNAc to GalNAc) .beta.1,6-N-acetylglucosaminyltransferase, C2/4GnT
7378498 Protein encoded by a nucleic acid
7354947 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto
7358230 Conserved diaphanous-related formin autoregulatory domain (DAD)
7368284 Porcine CMP-N-Acetylneuraminic acid hydroxylase gene
7368527 HADDE71 polypeptides
7368531 Human secreted proteins
7371388 Treatment of Sjogren's syndrome by administration of TR18 polypeptides
7371537 Modulators of B-lymphocyte activation, myosin-1F compositions and methods of use
7371540 Gene expression control DNA element and associated protein
7375192 Antibodies that specifically bind to chemokine beta-4
7375198 Modified nucleic acid probes
7413903 Methods of regulating differentiation in stem cells
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional